Windytimes Posted - 5 days ago

$IPSC selling to raise money at there prices is a sign of desperation. wtf

DonCorleone77 Posted - 6 days ago

$IPSC Century Therapeutics files to sell 15.87M shares of common stock for holders

DeepDown Posted - 1 week ago

$OMGA A lot of money to be made. $ALLR , $IKNA , $CMPX , $IPSC

BioMedicalRx Posted - 1 week ago

$IPSC I like the stock.

DonCorleone77 Posted - 1 week ago

$IPSC Century announces two presentations on CNTY-101 at ASGCT 27th Annual Meeting Century Therapeutics announced two poster presentations at the ASGCT 27th Annual Meeting. The data presented highlights the potential of the Company's lead candidate, CNTY-101, to treat B-cell driven autoimmune diseases including SLE. Additionally, the Company presented data which further demonstrates the capabilities of its Allo-Evasion technology through new preclinical data of a CD300a agonist which can potentially inhibit natural killer (NK) cell alloreactivity. Details of the posters are: Characterization of CNTY-101, an Allogeneic Anti-CD19 iPSC-Derived NK Product, for the Treatment of B Cell-Driven Autoimmune Diseases; and Immune Targeting and Approaches with Genetically-Modified Cells and Cell Therapies.

Stock_Titan Posted - 1 week ago

$IPSC Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting https://www.stocktitan.net/news/IPSC/century-therapeutics-presents-preclinical-data-highlighting-advances-c2hbet8vp3qy.html

biochirp Posted - 1 week ago

$IPSC ugly

Plungeprotectiongang Posted - 1 week ago

$IPSC Any hope left for my bags?

Stock_Titan Posted - 1 week ago

$IPSC Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates https://www.stocktitan.net/news/IPSC/century-therapeutics-reports-first-quarter-2024-financial-results-jl1ehouenefy.html

biochirp Posted - 04/26/24

$IPSC brother, early stage biotechs STINK

ShortBUTCHER Posted - 04/26/24

$IPSC has super high stats to see some covering or a breakout on the chart Also my main pick for now is **FRGT**! FRGT has NINETY DOLLAR PRICE TARGETS and a recent 8k and 10k that is literally jaw dropping

insiderbuyingselling Posted - 04/25/24

$IPSC new insider selling: 5000 shares. http://insiderbuyingselling.com/?t=IPSC

HaltTradeAlert Posted - 04/23/24

$IPSC Halt Time: 09:54:44 Issue Symbol: IPSC Reason Code: LUDP Last Price: $3.02 Market Cap: $195750056 Volume: 2646.0 Relative Volume: 0.02 Shares Float: 64817900 Our members get this alert real time and sent to their phone just like a text. Members also get free real time news catalyst alerts! Go to our website and join our community for free! www.HaltTradeAlert.com

Stock_Titan Posted - 04/23/24

$IPSC Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit https://www.stocktitan.net/news/IPSC/century-therapeutics-to-present-at-chardan-s-8th-annual-genetic-opljwtmx4kek.html

Windytimes Posted - 1 month ago

$IPSC I guess the market did not like the acquisition especially in this environment. Glad that they don’t care what the market thinks.. hopefully they are around in 2 years

Windytimes Posted - 1 month ago

$IPSC reading through the thread here, why is this down? And more importantly why are people thrilled? What is going on with this?

Observationalist Posted - 1 month ago

$IPSC Smart acquisition

briefingcom Posted - 1 month ago

$IPSC: Century Therapeutics strengthens position in autoimmune disease with strategic pipeline expansion supported by $60 million private placement and acquisition of Clade Therapeutics https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240411071251IPSC&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

biochirp Posted - 1 month ago

$IPSC 🤮

Stock_Titan Posted - 1 month ago

$IPSC Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics https://www.stocktitan.net/news/IPSC/century-therapeutics-strengthens-position-in-autoimmune-disease-with-5uftzk5y9cfj.html

valueforme Posted - 1 month ago

$IPSC 👀

DonCorleone77 Posted - 1 month ago

$IPSC 2 of 2 - Century Therapeutics: Data from iPSC-derived cell therapy presented at AACR ....T cell recognition through the elimination of HLA-I and HLA-II expression. This enhanced protection against rejection is designed to enable Century's multi-dosing strategy that increases the period of drug exposure, potentially leading to deeper and more durable responses for patients in need. We also presented new data describing our novel, dual-targeting CAR for B cell mediated malignancies which demonstrated promising in vitro and in vivo cytotoxicity and resisting antigen loss, and which we believe expands the potential of allogeneic CAR-T cell therapy beyond currently available options in oncology that only target CD19. Along with other important preclinical data presented at AACR, the findings to date highlight our unique gene editing, protein engineering, and manufacturing capabilities that are the foundations of our industry-leading allogeneic cell therapy pipeline and platform."

DonCorleone77 Posted - 1 month ago

$IPSC 1 of 2 - Century Therapeutics: Data from iPSC-derived cell therapy presented at AACR Century Therapeutics announced that preclinical data from the company's iPSC-derived cell therapy platform was presented at the AACR Annual Meeting 2024. The posters highlight the Company's end-to-end capabilities in iPSC reprogramming and differentiation, gene editing, synthetic biology, protein engineering and computational biology. "Together, the promising preclinical data showcase Century's continued dedication to driving the field of allogeneic cell therapy through the incorporation of a suite of innovations into next generation product candidates," said Hy Levitsky, M.D., President of Research and Development at Century Therapeutics. "We presented new data advancing our Allo-Evasion platform through the transgenic expression of HLA-G, which along with HLA-E can augment the protection against host natural killer cell-mediated rejection of iPSC derived cells also engineered to resist....

Stock_Titan Posted - 1 month ago

$IPSC Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting https://www.stocktitan.net/news/IPSC/century-therapeutics-presents-new-preclinical-data-highlighting-i-lta37lodoeyj.html

biochirp Posted - 03/27/24

$CRBU $IPSC

Stock_Titan Posted - 2 months ago

$IPSC Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference https://www.stocktitan.net/news/IPSC/century-therapeutics-to-present-at-the-h-c-wainwright-2nd-annual-k1awpyqhcuie.html

DonCorleone77 Posted - 2 months ago

$IPSC Century Therapeutics expects cash to support operations into 2026 The Company expects full year generally accepted accounting principles operating expenses to be between $135 million and $145 million. The Company estimates its cash, cash equivalents, and investments will support operations into 2026.

DonCorleone77 Posted - 2 months ago

$IPSC Century Therapeutics reports 2023 EPS ($2.30), consensus ($2.09) Reports 2023 revenue $2.2M, consensus $3.82M. "We enter 2024 following a series of significant milestones, highlighted by our presentation at ASH showcasing promising initial data from our ELiPSE-1 trial of CNTY-101. These findings not only revealed encouraging tolerability and early response signals in treating r/r B-cell lymphomas, but also unveiled the potential for a multi-dosing strategy while avoiding the need for continued lymphodepletion," said Brent Pfeiffenberger, Pharm.D., Chief Executive Officer of Century Therapeutics. "The early success of our Allo-Evasion technology, demonstrated by the recent ELiPSE-1 data, bolsters our confidence in the potential of this approach for prolonged and tighter control over drug exposure as we anticipate expansion into autoimmune indications, marked by the recent IND clearance of CNTY-101 in SLE...."

Stock_Titan Posted - 2 months ago

$IPSC Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates https://www.stocktitan.net/news/IPSC/century-therapeutics-reports-full-year-2023-financial-results-and-pox74josgvt6.html

PhillyTradez Posted - 2 months ago

$IPSC this one’s a winner. Congrats to those holding from under 3. Double digits most likely here.